These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15883754)

  • 21. A novel protective effect of erythropoietin in the infarcted heart.
    Parsa CJ; Matsumoto A; Kim J; Riel RU; Pascal LS; Walton GB; Thompson RB; Petrofski JA; Annex BH; Stamler JS; Koch WJ
    J Clin Invest; 2003 Oct; 112(7):999-1007. PubMed ID: 14523037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion.
    Lee BH; Yi KY; Lee S; Lee S; Yoo SE
    Eur J Pharmacol; 2005 Oct; 523(1-3):101-8. PubMed ID: 16226744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury.
    Cai Z; Semenza GL
    Circulation; 2004 May; 109(17):2050-3. PubMed ID: 15117842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription factor GATA-4 is involved in erythropoietin-induced cardioprotection against myocardial ischemia/reperfusion injury.
    Shan X; Xu X; Cao B; Wang Y; Guo L; Zhu Q; Li J; Que L; Chen Q; Ha T; Li C; Li Y
    Int J Cardiol; 2009 May; 134(3):384-92. PubMed ID: 18672303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia.
    Jun JH; Jun NH; Shim JK; Shin EJ; Kwak YL
    Eur J Pharmacol; 2014 Dec; 745():1-9. PubMed ID: 25446919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling.
    Miki T; Miura T; Yano T; Takahashi A; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Nishihara M; Naitoh K; Ohori K; Shimamoto K
    J Pharmacol Exp Ther; 2006 Apr; 317(1):68-75. PubMed ID: 16377761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Synthesized Radical-Containing Nanoparticles Limit Infarct Size Following Ischemia and Reperfusion in Canine Hearts.
    Asanuma H; Sanada S; Yoshitomi T; Sasaki H; Takahama H; Ihara M; Takahama H; Shinozaki Y; Mori H; Asakura M; Nakano A; Sugimachi M; Asano Y; Minamino T; Takashima S; Nagasaki Y; Kitakaze M
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):501-510. PubMed ID: 29101507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
    French CJ; Zaman AK; Sobel BE
    Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
    Miki T; Miura T; Tanno M; Nishihara M; Naitoh K; Sato T; Takahashi A; Shimamoto K
    Basic Res Cardiol; 2007 Mar; 102(2):163-70. PubMed ID: 16944359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
    Kim KH; Oudit GY; Backx PH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway.
    Tramontano AF; Muniyappa R; Black AD; Blendea MC; Cohen I; Deng L; Sowers JR; Cutaia MV; El-Sherif N
    Biochem Biophys Res Commun; 2003 Sep; 308(4):990-4. PubMed ID: 12927817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activation of PI 3-kinase/Akt pathway is involved in the acute effects of simvastatin against ischaemia and reperfusion-induced arrhythmias in anaesthetised dogs.
    Kisvári G; Kovács M; Seprényi G; Végh Á
    Eur J Pharmacol; 2015 Dec; 769():185-94. PubMed ID: 26597117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase.
    Sanada S; Asanuma H; Minamino T; Node K; Takashima S; Okuda H; Shinozaki Y; Ogai A; Fujita M; Hirata A; Kim J; Asano Y; Mori H; Tomoike H; Kitamura S; Hori M; Kitakaze M
    Circulation; 2004 Oct; 110(15):2143-9. PubMed ID: 15451788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.
    Wolfrum S; Dendorfer A; Schutt M; Weidtmann B; Heep A; Tempel K; Klein HH; Dominiak P; Richardt G
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):348-55. PubMed ID: 15475833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin enhances hydrogen peroxide-mediated dilatation of canine coronary collateral arterioles during myocardial ischemia in dogs in vivo.
    Yada T; Shimokawa H; Hiramatsu O; Satoh M; Kashihara N; Takaki A; Goto M; Ogasawara Y; Kajiya F
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1928-35. PubMed ID: 20870805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
    Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
    Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
    Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
    Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.